May 28, 2008FDA reviewing Pfizer anti-smoking drug - Reuters FDA reviewing Pfizer anti-smoking drug - Reuters
SILVER SPRING, Maryland (Reuters) - The Food and Drug Administration is taking a closer look at Pfizer Inc's anti-smoking drug Chantix after reports of hundreds of patients experiencing serious problems, an agency official told Reuters on Tuesday Source: www.reuters.com CLRS Technology Accelerates Infrastructure Growth Anticipating FDA - MSN MoneyCentral COSTA MESA, Calif., May 28 /PRNewswire/ -- CLRS Technology today announced a series of corporate milestones in anticipation of FDA clearance for CLARO, the company's innovative at-home acne treatment device. Key business developments include the Source: news.moneycentral.msn.com ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck - MSN MoneyCentral Introgen Therapeutics, Inc. INGN today announced that ADVEXIN(R) (p53 tumor suppressor therapy) significantly increased survival in end-stage head and neck cancer patients with prospectively identified p53 favorable profiles (7.2 vs. 2.7 months; p Source: news.moneycentral.msn.com ZymoGenetics gets FDA approval for larger version of Recothrom - CNBC NEW YORK (Thomson Financial) - ZymoGenetics Inc. Tuesday said the Food and Drug Administration approved a prior approval supplement application for a larger version of its Recothrom product. The new version is a 20,000 international unit vial. A 5 Source: www.cnbc.com FDA's footdragging hurts Canada's biotech firms - Boston Globe TORONTO (Reuters) - Canadian biotechnology companies have joined a chorus of their global counterparts to rail against the U.S. Food and Drug Administration's tardiness in approving new drugs. Products by companies such as Labopharm Inc Source: www.boston.com # posted by Network @ 5:00 AM
 |
Subscribe to Posts [Atom]